Your browser doesn't support javascript.
loading
CB1 receptor mediates the effects of glucocorticoids on AMPK activity in the hypothalamus.
Scerif, Miski; Füzesi, Tamás; Thomas, Julia D; Kola, Blerina; Grossman, Ashley B; Fekete, Csaba; Korbonits, Márta.
Afiliación
  • Scerif M; Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK Department of Endocrine Neurobiology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest 1083, Hungary Division of Endocrinology, Diabetes, Metabolism and Molecular Medicine, Department of Medicine, Tupper Research Institute, Tufts Medical Center, Boston, Massachusetts 02111, USA Oxford Centre for Diabete
J Endocrinol ; 219(1): 79-88, 2013 Oct.
Article en En | MEDLINE | ID: mdl-23884964

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Síndrome de Cushing / Receptor Cannabinoide CB1 / Proteínas Quinasas Activadas por AMP / Glucocorticoides / Hipotálamo Tipo de estudio: Prognostic_studies Idioma: En Revista: J Endocrinol Año: 2013 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Síndrome de Cushing / Receptor Cannabinoide CB1 / Proteínas Quinasas Activadas por AMP / Glucocorticoides / Hipotálamo Tipo de estudio: Prognostic_studies Idioma: En Revista: J Endocrinol Año: 2013 Tipo del documento: Article